HAMBURG, Germany, Dec. 5, 2022 /PRNewswire/ — apoQlar, a German medical technology company, today announced it has received FDA 510(k) Class II clearance for VSI HoloMedicine®, a pioneering mixed […]
HAMBURG, Germany, Dec. 5, 2022 /PRNewswire/ — apoQlar, a German medical technology company, today announced it has received FDA 510(k) Class II clearance for VSI HoloMedicine®, a pioneering mixed […]